Overview
Childhood encephalopathy due to thiamine pyrophosphokinase (TPK1) deficiency is an extremely rare inherited metabolic disorder that affects the brain and nervous system. The condition is caused by problems with the TPK1 enzyme, which is responsible for converting thiamine (vitamin B1) into its active form called thiamine pyrophosphate. This active form of thiamine is essential for energy production in cells, especially in the brain. When the enzyme does not work properly, the brain and other organs cannot produce enough energy, leading to progressive damage. Children with this condition typically develop normally at first but then begin to lose skills they had already learned, a process called developmental regression. Common symptoms include episodes of brain dysfunction (encephalopathy), difficulty walking and coordinating movements (ataxia), muscle stiffness or weakness, seizures, and progressive intellectual disability. Some children may also experience dystonia, which causes involuntary muscle contractions and abnormal postures. Treatment focuses on supplementing with high doses of thiamine (vitamin B1) and sometimes biotin, which may help slow disease progression in some patients if started early. However, the response to treatment varies, and many children still experience significant neurological problems despite supplementation. Early diagnosis and prompt treatment are important to give the best chance of preserving brain function. This condition is also known as TPK1 deficiency or thiamine metabolism dysfunction syndrome 5 (THMD5).
Key symptoms:
Loss of previously learned skills (developmental regression)Episodes of brain dysfunction (encephalopathy)Difficulty walking and poor coordination (ataxia)SeizuresMuscle stiffness and spasticityInvoluntary muscle contractions causing abnormal postures (dystonia)Intellectual disabilityDifficulty speaking or loss of speechMuscle weaknessDifficulty swallowingAbnormal eye movementsPoor growth or failure to thriveFatigue and low energy
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Childhood encephalopathy due to thiamine pyrophosphokinase deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Childhood encephalopathy due to thiamine pyrophosphokinase deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Childhood encephalopathy due to thiamine pyrophosphokinase deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Childhood encephalopathy due to thiamine pyrophosphokinase deficiency.
Community
No community posts yet. Be the first to share your experience with Childhood encephalopathy due to thiamine pyrophosphokinase deficiency.
Start the conversation →Latest news about Childhood encephalopathy due to thiamine pyrophosphokinase deficiency
No recent news articles for Childhood encephalopathy due to thiamine pyrophosphokinase deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What dose of thiamine should my child take, and how often should it be adjusted?,What signs should I watch for that would indicate an acute encephalopathy episode?,What should I do if my child develops a fever or becomes sick — is there an emergency protocol?,How often should brain MRI and other monitoring tests be repeated?,Are there any clinical trials or new treatments being studied for TPK1 deficiency?,What therapies (physical, occupational, speech) would benefit my child the most right now?,Should other family members be tested for carrier status or the condition itself?
Common questions about Childhood encephalopathy due to thiamine pyrophosphokinase deficiency
What is Childhood encephalopathy due to thiamine pyrophosphokinase deficiency?
Childhood encephalopathy due to thiamine pyrophosphokinase (TPK1) deficiency is an extremely rare inherited metabolic disorder that affects the brain and nervous system. The condition is caused by problems with the TPK1 enzyme, which is responsible for converting thiamine (vitamin B1) into its active form called thiamine pyrophosphate. This active form of thiamine is essential for energy production in cells, especially in the brain. When the enzyme does not work properly, the brain and other organs cannot produce enough energy, leading to progressive damage. Children with this condition typic
How is Childhood encephalopathy due to thiamine pyrophosphokinase deficiency inherited?
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Childhood encephalopathy due to thiamine pyrophosphokinase deficiency typically begin?
Typical onset of Childhood encephalopathy due to thiamine pyrophosphokinase deficiency is childhood. Age of onset can vary across affected individuals.